Nautilus Biotechnolgy, Inc.
- NAUT
- NASDAQ
- Biotechnology
- Proteomics Platform
- Life Science Tools
- Protein Analysis Technology
$2.06
Today −4.63%Quote Oct 16, 2026, 08:00 PM UTC
+112.00%over the last month
Max drawdown −9.7%From 1-month high −8.4%3 months +21.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$262.1M
Quote Oct 16
Next earnings
Oct 27
Expected, not confirmed
Analyst target
$3.50
+69.9% from here
Floor
$1.86
9.7% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about NAUTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $195,000
- Grant Revenue$180,00092.3%
- Service Revenue$15,0007.7%
Industry
Biotechnology
Employees
127
Founded
2016